This study looks at a medicine called cenobamate, which is being tested for safety and effectiveness in kids aged 2 to 17 with partial-onset seizures. Seizures are sudden bursts of electrical activity in the brain. The main goal is to make sure this medicine is safe and can be tolerated by children.

Inclusion in the study requires: having a type of epilepsy called partial-onset seizures, weighing at least 22 pounds, and being on stable doses of 1 to 3 other epilepsy medicines. Some kids cannot join, such as those who are pregnant, have pseudo-seizures, or have other major health issues. The study checks how the medicine is absorbed and works in the body. Kids might need to try tablets or a liquid form of the medicine, and give feedback on taste.

Key Points:

• The study is for children aged 2-17 with specific types of seizures.
• Participants must take stable doses of 1-3 other seizure medicines.
• Some health conditions might prevent participation.